Lentiviral mediated delivery of CRISPR/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucoma.
Patil SV, Kaipa BR, Ranshing S, Sundaresan Y, Millar JC, Nagarajan B, Kiehlbauch C, Zhang Q, Jain A, Searby CC, Scheetz TE, Clark AF, Sheffield VC, Zode GS.
Patil SV, et al. Among authors: millar jc.
Sci Rep. 2024 Mar 23;14(1):6958. doi: 10.1038/s41598-024-57286-6.
Sci Rep. 2024.
PMID: 38521856
Free PMC article.